Moderna eyes Omicron-specific jab in 2022

By Georgie Moore and Dominic Giannini
Updated January 27 2022 - 7:41pm, first published 7:35pm
Pharmaceutical company Moderna is testing its Omicron-specific COVID-19 booster vaccine.
Pharmaceutical company Moderna is testing its Omicron-specific COVID-19 booster vaccine.

Pharmaceutical company Moderna aims to have its Omicron-specific COVID-19 booster vaccine on the market by the third quarter of 2022.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options